NCT00007033
- Conditions
- Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +18 more
- Locations
-
- Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States
Clinical trial condition
Bile Duct Diseases
Explore clinical trials studying Bile Duct Diseases. Study availability and eligibility vary by location and protocol.
667 public trials
130 recruiting studies
Bile Duct Diseases trial results
NCT00001642
- Conditions
- Abnormalities, Multiple, Alagille Syndrome, Aneuploidy, +17 more
- Locations
-
- National Human Genome Research Institute (NHGRI) Bethesda, Maryland, United States
NCT00490620
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- St Louis University St Louis, Missouri, United States
- University of Alberta Edmonton, Alberta, Canada
- University of Montreal Montreal, Quebec, Canada
Completed
Expression of BCRP in Icteric Patients
NCT00295360
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
- Locations
-
- University Basel, Department of Research Basel, Canton of Basel-City, Switzerland
NCT00173368
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Choledocholithiasis, +7 more
- Locations
-
Not specified
Completed
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
NCT00004784
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
- Locations
-
Not specified
NCT00004748
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
- Locations
-
Not specified
NCT00004762
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +7 more
- Locations
-
Not specified
Active, Not Recruiting
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
NCT05277766
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Appendiceal Neoplasms, +37 more
- Locations
-
- UZ Ghent Ghent, East-Flanders, Belgium
Active, Not Recruiting
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
NCT06109779
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States